Amylose.
Research-backed compound with potential health benefits. Amylose is the straight-chain half of starch. Cooked and cooled, a good share of it resists digestion and reaches your colon, where your bacteria ferment it into butyrate.
Reviewed March 2026
- Category
- Compound
What Amylose is, and what it does.
- Does it work
- Suits you if fibre runs thin in your week, if you're supporting healthy glucose metabolism, or if you want steadier fullness between meals. Build the amount up slowly.
- How much to take
- Start with 5-10 grams (about 1-2 teaspoons) per day and slowly work up to 15-30 grams. Mix it into a smoothie or yogurt.
- Time to feel it
- Fermentation picks up within a few days, often as extra gas early on. The gut and glucose measures people track move over roughly two to four weeks of daily use.
- The first dose
- Nothing, unless you take too much. Then you'll feel gassy. The real benefits are not immediate.
- With regular use
- After a month, you may notice improved digestive regularity and reduced appetite. Over time, it contributes to a healthier gut microbiome, which has wide-ranging health benefits.
- How well tolerated
- Well tolerated. It's a natural component of many foods. The only 'danger' is digestive discomfort if you don't gradually increase your dose.
- How it feels
- You don't feel it 'work'. The effects are indirect: better digestion, feeling fuller, more stable energy. It's a background player for your health.
- The overlooked benefit
- Reheating doesn't undo it. Once cooked starch has cooled and retrograded, much of the resistant fraction survives a reheat, so yesterday's rice keeps it.
5 to 15g a day is where Amylose works.
Source: Based on resistant starch research; Bodinham et al. Nutr Bull 2012
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Amylose is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- Colonic short chain fatty acid productionRandomised trial
- Blood glucose response after a mealMeta-analysis
- Insulin response already in the normal rangeRandomised trial
- Gut microbiota compositionSystematic review
- Stool bulk and bowel regularityRandomised trial
- Satiety and food intake at the next mealRandomised trial
- Blood lipids already in the normal rangeRandomised trial
Questions people ask about Amylose.
- Will this make me bloated and gassy?
- Only if you start with too high a dose. Begin with one teaspoon a day for a week, then slowly increase. This gives your gut bacteria time to adjust.
- Can I cook with it?
- Don't. Heat breaks down this type of resistant starch, which defeats the purpose. Mix it into cool or room-temperature foods like smoothies, yogurt, or just water.
- Is this the same as regular cornstarch?
- No. This is a specific high-amylose starch designed to resist digestion. Regular cornstarch from the grocery store won't have the same prebiotic effects.
- Does it help with weight loss?
- It can help by making you feel fuller, so you eat less. It's a tool, not a magic pill. No fiber supplement will make you lose weight without diet and exercise.
- What's the best time of day to take it?
- Anytime works. Many people add it to their morning smoothie. Consistency is more important than timing.
- Can I just get this from food?
- Yes. Cooked and cooled potatoes, rice, green bananas, and legumes are all great sources. The supplement is just a convenient, concentrated option.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
When cooked amylose cools, its linear chains realign into tight double helices that pancreatic amylase cannot open. That retrograded material is type 3 resistant starch, so a high amylose content is the compositional precondition for it. Resistant starch on a label is often high amylose maize starch that has been through a controlled heat and cool cycle.
Starch that escapes small intestinal digestion is fermented by colonic bacteria, and resistant starch is notably butyrogenic compared with many other fermentable substrates. Butyrate is the preferred fuel of colonocytes. Supplying the substrate and supplying the end product are two different strategies toward the same molecule.
Alpha amylase hydrolyses internal alpha 1,4 bonds, and amylose is its substrate. Crystalline and retrograded amylose is physically inaccessible to the enzyme, which is what makes it resistant rather than any chemical difference in the bonds. Adding supplemental amylase raises the digestible fraction and works against the reason a formula would use high amylose material.
Broad digestive enzyme blends contain amylase, so taking one alongside a high amylose ingredient increases the fraction broken down in the small intestine. That reduces what reaches the colon for fermentation. Whether this matters depends entirely on which of the two effects the formula is after.
1 deoxynojirimycin from white mulberry inhibits intestinal alpha glucosidase, the enzyme that finishes converting starch fragments into glucose. High amylose starch slows the earlier hydrolysis step. The two act at different points on the same digestion sequence, so the effect on post meal glucose, a marker, would be expected to add. Combination data are limited.
Tea polyphenols bind alpha amylase and also complex directly with starch chains, both of which slow hydrolysis in laboratory digestion models. Amylose contributes the resistant fraction from the substrate side. Most of this evidence is in vitro, and post meal glucose is a marker rather than an outcome.
Proanthocyanidins bind starch granules and digestive enzymes, lowering the rate of glucose release in laboratory digestion models. Combined with a high amylose substrate the effects are expected to stack. The evidence is in vitro and does not establish a human effect.
Free fatty acids slot into the helical cavity of amylose to form inclusion complexes, the material classified as type 5 resistant starch. The complex resists amylase and changes the pasting behaviour of the starch. This is why lipid content in a food matrix changes how digestible its starch is.
Monoacyl phospholipids from lecithin complex with amylose in the same helical cavity that free fatty acids occupy. In food processing this is used deliberately to control staling and texture. In a supplement matrix it changes the digestible fraction of the starch present.
Inulin ferments quickly and mostly in the proximal colon while resistant amylose ferments slowly and reaches further along. Combining them spreads substrate across more of the large bowel. The same additive property raises total gas production, which is the reason to build the dose up gradually.
Short chain fructooligosaccharides are fermented rapidly near the start of the colon, complementing the slower distal fermentation of retrograded amylose. The pairing widens the fermentation profile. Combined fermentable loads add up, and gas and bloating track the total.
Several bifidobacteria carry the enzymes to degrade resistant starch granules and are among the primary degraders in the colon. Their fermentation products are then cross fed to butyrate producing species. Strain differences in starch utilisation are large, so this does not generalise across all bifidobacteria.
Plantarum strains use the sugars and lactate released when primary degraders break down starch rather than attacking granules directly. That places them second in the fermentation chain. The pairing is common in synbiotic products and rests on ecology rather than on combination trials.
Oat beta glucan works mainly through viscosity in the small intestine while resistant amylose works through escaping digestion altogether. The two mechanisms are separate and both bear on post meal glucose, a marker. Combining them also raises the total fibre load in one dose.
Psyllium adds gel forming bulk that is only partly fermented, while resistant amylose is largely fermented. Together they cover both the bulking and the fermentation sides of fibre behaviour. The pairing is formulation logic supported by each fibre's own literature rather than by a combination trial.
Fermentation acidifies the colonic lumen and short chain fatty acids keep calcium in solution, which has been associated with greater calcium absorption in the large bowel in some studies. The measured endpoints are usually absorption markers. An association here is not a demonstrated effect on bone.
Proteins can form a physical barrier around starch granules and interact with leached amylose, slowing enzyme access in laboratory digestion models. The effect depends heavily on processing and heat. This is food matrix chemistry rather than a supplement pairing with human data.
Iodine slots into the amylose helix and produces the deep blue complex that has been used to measure amylose content for over a century, with amylopectin giving a reddish brown instead. This is an analytical property, not a reason to take the two together. It is the assay behind most amylose content figures on a specification sheet.
Nothing specific on file for Amylose. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Amylose actually does.
Amylose is the essentially linear fraction of starch, made of glucose units joined by alpha 1,4 bonds with very few alpha 1,6 branch points. Amylopectin is the heavily branched fraction. Native starches typically run around twenty to thirty percent amylose; high amylose maize hybrids reach fifty to eighty percent.
Linear amylose chains realign into tightly packed double helices as a cooked starch paste cools. That retrograded structure is physically inaccessible to pancreatic alpha amylase, which is why it becomes type 3 resistant starch. The bonds are unchanged; only the packing is.
Amylose adopts a single helix with a hydrophobic interior that admits linear guest molecules such as free fatty acids, monoglycerides and iodine. Complexed with a lipid it is classified as type 5 resistant starch and resists digestion for the same steric reason.
Starch that reaches the colon undigested is fermented by the resident microbiota to short chain fatty acids, principally acetate, propionate and butyrate. Colonocytes take up butyrate as their preferred fuel, which is the basis for describing resistant starch as supporting normal gut barrier function.
Where Amylose comes from.
Corn bred to be unusually high in amylose is soaked, ground and separated into its parts, and the starch is washed clean. Some products are then cooked and cooled on purpose, because that is what turns the starch into the form that resists digestion. The powder is tested for how much amylose and resistant starch it actually contains.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Maize hybrids bred conventionally for the amylose extender trait, which raises amylose content well above ordinary dent maize. Potato and pea starches are used in some products.
Kernels are steeped in warm water with sulfur dioxide to soften them, then milled and separated into germ, fibre, protein and starch fractions by density.
The starch slurry is washed over hydrocyclones to strip residual protein and soluble matter, then dewatered.
Where a retrograded fraction is wanted, the starch is gelatinised and cooled under a controlled profile so amylose chains recrystallise. Native granular material skips this step.
Amylose content is quantified, usually by iodine binding, and the resistant starch fraction is measured by an enzymatic digestion method.
Flash or spray dried and milled to a free flowing white powder for capsules, sachets or food inclusion.
Labels often state resistant starch content without saying which type it is, and native granular, retrograded and lipid complexed material behave differently in heat and in the gut.
Getting Amylose from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- In healthy adults, supplementation with non-digestible carbohydrates including resistant starch changed the make-up of the gut bacteria and raised microbial metabolite levels compared with the control period.Randomised trial. Malcomson et al., 2024 (The British journal of nutrition). PMID 39494600 ↗
- Reviewing human feeding studies, cereal fibres including resistant starch had only a modest and inconsistent effect on how full people reported feeling after eating.Systematic review. Machalias et al., 2026 (Nutrition reviews). PMID 40644449 ↗
- In adults with reduced kidney filtration, high-amylose resistant starch shifted the gut bacterial profile, while the change in circulating gut-derived metabolites did not clearly differ from the control group.Randomised trial. Headley et al., 2025 (Journal of renal nutrition). PMID 39362281 ↗
- Early life exposure to high amylose maize starch produced long lasting changes in glucose homeostasis measures in the model used.Animal study. Xu et al., 2026 (Food Research International). PMID 42083173 ↗
- Single helical maize amylose increased steamed bun hardness, with the authors attributing the texture change to how the helical amylose interacts with the gluten network.In vitro study. Yu et al., 2026 (Foods). PMID 42196024 ↗
- Wheat bran insoluble dietary fibre altered the physicochemical and structural properties of the starch system and slowed its digestion in the simulated model.In vitro study. Li et al., 2026 (Food Chemistry: X). PMID 42436757 ↗
- Formulation changes to defatted pea starch noodles shifted structural transitions and lowered measured starch digestibility.In vitro study. Asiamah et al., 2026 (Food Research International). PMID 41956652 ↗
- Reformulating a traditional flatbread raised its resistant starch content substantially and lowered its measured glycaemic index.In vitro study. Ozer et al., 2026 (Foods). PMID 42195959 ↗
- The review describes how type 5 resistant starch, the amylose lipid complex, resists digestion and shifts gut microbial composition and short chain fatty acid output.Narrative review. Ahmmed et al., 2026 (Engineering Microbiology). PMID 41982390 ↗
- Resistant starch enriched rice altered metabolic markers in mice fed a high fat diet compared with the control diet.Animal study. Im et al., 2026 (Journal of Food Science). PMID 42186153 ↗
These are the studies our verdict leans on, chosen from the 1,894 we read for Amylose. The full linked list is below.
The studies, linked.
9 sources behind our Amylose verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialCapacity of Amylose Characterisation Compare by Immunohistochemistry and Proteomic Analysis. Multicenter ProspectiveClinicalTrials.gov ↗NA · 140 participants · Completed
- Clinical trialRole of Slowly Digesible Starch on Diabetes Risk Factors In Pre-diabetic PeopleClinicalTrials.gov ↗NA · 65 participants · Completed
- Clinical trialHigh-amylose Barley (HIAMBA) in the Regulation and Prevention of Type 2 Diabetes: a Randomized, Cross-over, Acute Dietary Intervention Study.ClinicalTrials.gov ↗NA · 38 participants · Completed
- Clinical trialMetabolic Effects of High-amylose Wheat-based Breads in Overweight IndividualsClinicalTrials.gov ↗NA · 20 participants · Completed
- ClinicalTrials.gov ↗
- Clinical trialAssessment of Gastric Emptying and Fullness of Rice With Different Starch PropertiesClinicalTrials.gov ↗NA · 12 participants · Completed
- Clinical trialEvaluating the Effect of Prebiotics on the Gut Microbiome Profile and Beta Cell Function in Newly Diagnosed Type 1 DiabetesClinicalTrials.gov ↗PHASE1 · 12 participants · Completed
- Clinical trialMetabolic Effects of High-amylose Wheat-based Rusks in Healthy Subjects. A Pilot Study.ClinicalTrials.gov ↗NA · 10 participants · Completed
- Clinical trialNOMAC : New Tools for Managing the Fate of Cereal Nutrients in the Gut : Effects of Amylose Content on Glycemic Index.ClinicalTrials.gov ↗NA · 10 participants · Completed
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.